<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38675423</PMID><DateRevised><Year>2024</Year><Month>04</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">1424-8247</ISSN><JournalIssue CitedMedium="Print"><Volume>17</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>Apr</Month><Day>05</Day></PubDate></JournalIssue><Title>Pharmaceuticals (Basel, Switzerland)</Title><ISOAbbreviation>Pharmaceuticals (Basel)</ISOAbbreviation></Journal><ArticleTitle>Potential Anti-Inflammatory and Anti-Fatigue Effects of an Oral Food Supplement in Long COVID Patients.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">463</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ph17040463</ELocationID><Abstract><AbstractText>Long coronavirus disease (COVID) syndrome leads to chronic inflammatory state onset that can have a multisystem impact and compromise organ function. Moreover, long COVID syndrome is often characterized by the presence of chronic fatigue, which affects subjects' daily activities and worsens their quality of life. The aim of our double-blind, placebo-controlled randomized trial (protocol code RS 150.21, approved on 4 November 2021) was to evaluate the beneficial effects of the consumption of 2 cps/day, for two months, of an oral food supplement (OFS), based on <i>Echinacea angustifolia</i>, rosehip, propolis, royal jelly and zinc, in long COVID patients, compared to a two-month placebo period. The OFS's vitamin C content was equal to 22.17 mg/g (8.87 mg/capsule). The OFS's total polyphenol content was 43.98 mg/g gallic acid equivalents. At the end of the in vivo study, we highlighted a significant decrease in the inflammatory parameters in the OFS period, compared to the placebo period (neutrophil-to-lymphocyte ratio, <i>p</i> = 0.0455; monocyte to-lymphocyte ratio, <i>p</i> = 0.0005; C-reactive protein, <i>p</i> = 0.0145). Our study also highlighted a significant increase in vitamin D serum values (<i>p</i> = 0.0005) and, at the same time, an improvement in patients' life quality and a reduction in fatigue, monitored by the fatigue severity scale. This study showed the OFS's beneficial effects on the inflammatory state, fatigue and quality of life in long COVID patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Noce</LastName><ForeName>Annalisa</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-1310-3730</Identifier><AffiliationInfo><Affiliation>UOSD Nephrology and Dialysis, Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marrone</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-5854-2086</Identifier><AffiliationInfo><Affiliation>UOSD Nephrology and Dialysis, Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Lauro</LastName><ForeName>Manuela</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-8118-1330</Identifier><AffiliationInfo><Affiliation>UOSD Nephrology and Dialysis, Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vita</LastName><ForeName>Chiara</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-9190-6550</Identifier><AffiliationInfo><Affiliation>QuMAP-PIN, University Center "Citt&#xe0; di Prato" Educational and Scientific Services for the University of Florence, 59100 Prato, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montalto</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>School of Specialization in Nephrology, University of Rome Tor Vergata, 00133 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giorgino</LastName><ForeName>Gloria</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>School of Specialization in Nephrology, University of Rome Tor Vergata, 00133 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chiaramonte</LastName><ForeName>Carlo</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Statistics, University of Rome Tor Vergata, 00133 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'Agostini</LastName><ForeName>Cartesio</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Experimental Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Clinical Microbiology, Policlinico Tor Vergata, 00133 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bernardini</LastName><ForeName>Sergio</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Experimental Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Tor Vergata University Hospital, 00133 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pieri</LastName><ForeName>Massimo</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-3463-0268</Identifier><AffiliationInfo><Affiliation>Department of Experimental Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Tor Vergata University Hospital, 00133 Rome, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Pharmaceuticals (Basel)</MedlineTA><NlmUniqueID>101238453</NlmUniqueID><ISSNLinking>1424-8247</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">adjuvant treatment</Keyword><Keyword MajorTopicYN="N">cytokine storm</Keyword><Keyword MajorTopicYN="N">fatigue</Keyword><Keyword MajorTopicYN="N">inflammatory state</Keyword><Keyword MajorTopicYN="N">long COVID syndrome</Keyword><Keyword MajorTopicYN="N">natural bioactive compounds</Keyword><Keyword MajorTopicYN="N">oxidative stress</Keyword><Keyword MajorTopicYN="N">quality of life</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>3</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>27</Day><Hour>9</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>27</Day><Hour>9</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>27</Day><Hour>1</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>4</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38675423</ArticleId><ArticleId IdType="pmc">PMC11053797</ArticleId><ArticleId IdType="doi">10.3390/ph17040463</ArticleId><ArticleId IdType="pii">ph17040463</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rothan H.A., Byrareddy S.N. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J. Autoimmun. 2020;109:102433. doi: 10.1016/j.jaut.2020.102433.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2020.102433</ArticleId><ArticleId IdType="pmc">PMC7127067</ArticleId><ArticleId IdType="pubmed">32113704</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson B.K., Guevara-Coto J., Yogendra R., Francisco E.B., Long E., Pise A., Rodrigues H., Parikh P., Mora J., Mora-Rodriguez R.A. Immune-Based Prediction of COVID-19 Severity and Chronicity Decoded Using Machine Learning. Front. Immunol. 2021;12:700782. doi: 10.3389/fimmu.2021.700782.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.700782</ArticleId><ArticleId IdType="pmc">PMC8273732</ArticleId><ArticleId IdType="pubmed">34262570</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner S., Khan M.A., Putrino D., Woodcock A., Kell D.B., Pretorius E. Long COVID: Pathophysiological factors and abnormalities of coagulation. Trends Endocrinol. Metab. 2023;34:321&#x2013;344. doi: 10.1016/j.tem.2023.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tem.2023.03.002</ArticleId><ArticleId IdType="pmc">PMC10113134</ArticleId><ArticleId IdType="pubmed">37080828</ArticleId></ArticleIdList></Reference><Reference><Citation>Borczuk A.C., Yantiss R.K. The pathogenesis of coronavirus-19 disease. J. Biomed. Sci. 2022;29:87. doi: 10.1186/s12929-022-00872-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-022-00872-5</ArticleId><ArticleId IdType="pmc">PMC9597981</ArticleId><ArticleId IdType="pubmed">36289507</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C., Haupert S.R., Zimmermann L., Shi X., Fritsche L.G., Mukherjee B. Global Prevalence of Post-Coronavirus Disease 2019 (COVID-19) Condition or Long COVID: A Meta-Analysis and Systematic Review. J. Infect. Dis. 2022;226:1593&#x2013;1607. doi: 10.1093/infdis/jiac136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho K., Park S., Kim E.Y., Koyanagi A., Jacob L., Yon D.K., Lee S.W., Kim M.S., Radua J., Elena D., et al. Immunogenicity of COVID-19 vaccines in patients with diverse health conditions: A comprehensive systematic review. J. Med. Virol. 2022;94:4144&#x2013;4155. doi: 10.1002/jmv.27828.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27828</ArticleId><ArticleId IdType="pmc">PMC9347877</ArticleId><ArticleId IdType="pubmed">35567325</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan F.J., Hope C.M., Masavuli M.G., Lynn M.A., Mekonnen Z.A., Yeow A.E.L., Garcia-Valtanen P., Al-Delfi Z., Gummow J., Ferguson C., et al. Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection. BMC Med. 2022;20:26. doi: 10.1186/s12916-021-02228-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-02228-6</ArticleId><ArticleId IdType="pmc">PMC8758383</ArticleId><ArticleId IdType="pubmed">35027067</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J.H., Kim J.Y., Lee S., Lee S., Stubbs B., Koyanagi A., Dragioti E., Jacob L., Carvalho A.F., Radua J., et al. Environmental risk factors, protective factors, and biomarkers for postpartum depressive symptoms: An umbrella review. Neurosci. Biobehav. Rev. 2022;140:104761. doi: 10.1016/j.neubiorev.2022.104761.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2022.104761</ArticleId><ArticleId IdType="pubmed">35803397</ArticleId></ArticleIdList></Reference><Reference><Citation>Joli J., Buck P., Zipfel S., Stengel A. Post-COVID-19 fatigue: A systematic review. Front. Psychiatry. 2022;13:947973. doi: 10.3389/fpsyt.2022.947973.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2022.947973</ArticleId><ArticleId IdType="pmc">PMC9403611</ArticleId><ArticleId IdType="pubmed">36032234</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenthal T.C., Majeroni B.A., Pretorius R., Malik K. Fatigue: An overview. Am. Fam. Physician. 2008;78:1173&#x2013;1179.</Citation><ArticleIdList><ArticleId IdType="pubmed">19035066</ArticleId></ArticleIdList></Reference><Reference><Citation>Giuliano M., Tiple D., Agostoni P., Armocida B., Biardi L., Bonfigli A.R., Campana A., Ciardi M., Di Marco F., Floridia M., et al. Italian good practice recommendations on management of persons with Long-COVID. Front. Public. Health. 2023;11:1122141. doi: 10.3389/fpubh.2023.1122141.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2023.1122141</ArticleId><ArticleId IdType="pmc">PMC10157646</ArticleId><ArticleId IdType="pubmed">37151592</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: Major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran A.V., Jayadevan R., Sashidharan S. Long COVID: An overview. Diabetes Metab. Syndr. 2021;15:869&#x2013;875. doi: 10.1016/j.dsx.2021.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.04.007</ArticleId><ArticleId IdType="pmc">PMC8056514</ArticleId><ArticleId IdType="pubmed">33892403</ArticleId></ArticleIdList></Reference><Reference><Citation>Noce A., Albanese M., Marrone G., Di Lauro M., Pietroboni Zaitseva A., Palazzetti D., Guerriero C., Paolino A., Pizzenti G., Di Daniele F., et al. Ultramicronized Palmitoylethanolamide (um-PEA): A New Possible Adjuvant Treatment in COVID-19 patients. Pharmaceuticals. 2021;14:336. doi: 10.3390/ph14040336.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph14040336</ArticleId><ArticleId IdType="pmc">PMC8067485</ArticleId><ArticleId IdType="pubmed">33917573</ArticleId></ArticleIdList></Reference><Reference><Citation>Albanese M., Marrone G., Paolino A., Di Lauro M., Di Daniele F., Chiaramonte C., D&#x2019;Agostini C., Romani A., Cavaliere A., Guerriero C., et al. Effects of Ultramicronized Palmitoylethanolamide (um-PEA) in COVID-19 Early Stages: A Case-Control Study. Pharmaceuticals. 2022;15:253. doi: 10.3390/ph15020253.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph15020253</ArticleId><ArticleId IdType="pmc">PMC8878249</ArticleId><ArticleId IdType="pubmed">35215365</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho K., Park S., Koyanagi A., Jacob L., Yon D.K., Lee S.W., Kim M.S., Kim S.U., Kim B.K., Shin J.I., et al. The effect of pharmacological treatment and lifestyle modification in patients with nonalcoholic fatty liver disease: An umbrella review of meta-analyses of randomized controlled trials. Obes. Rev. 2022;23:e13464. doi: 10.1111/obr.13464.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/obr.13464</ArticleId><ArticleId IdType="pubmed">35582982</ArticleId></ArticleIdList></Reference><Reference><Citation>Ribeiro R., Botelho F.D., Pinto A.M.V., La Torre A.M.A., Almeida J., LaPlante S.R., Franca T.C.C., Veiga-Junior V.F., Dos Santos M.C. Molecular modeling study of natural products as potential bioactive compounds against SARS-CoV-2. J. Mol. Model. 2023;29:183. doi: 10.1007/s00894-023-05586-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00894-023-05586-5</ArticleId><ArticleId IdType="pmc">PMC10201022</ArticleId><ArticleId IdType="pubmed">37212923</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Renzo L., Gualtieri P., Romano L., Marrone G., Noce A., Pujia A., Perrone M.A., Aiello V., Colica C., De Lorenzo A. Role of Personalized Nutrition in Chronic-Degenerative Diseases. Nutrients. 2019;11:1707. doi: 10.3390/nu11081707.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu11081707</ArticleId><ArticleId IdType="pmc">PMC6723746</ArticleId><ArticleId IdType="pubmed">31344895</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahbap E., Sakaci T., Kara E., Sahutoglu T., Koc Y., Basturk T., Sevinc M., Akgol C., Kayalar A.O., Ucar Z.A., et al. Neutrophil-to-lymphocyte ratio and platelet-tolymphocyte ratio in evaluation of inflammation in end-stage renal disease. Clin. Nephrol. 2016;85:199&#x2013;208. doi: 10.5414/CN108584.</Citation><ArticleIdList><ArticleId IdType="doi">10.5414/CN108584</ArticleId><ArticleId IdType="pubmed">26521887</ArticleId></ArticleIdList></Reference><Reference><Citation>Bharadwaj S., El-Kafrawy S.A., Alandijany T.A., Bajrai L.H., Shah A.A., Dubey A., Sahoo A.K., Yadava U., Kamal M.A., Azhar E.I., et al. Structure-Based Identification of Natural Products as SARS-CoV-2 M(pro) Antagonist from Echinacea angustifolia Using Computational Approaches. Viruses. 2021;13:305. doi: 10.3390/v13020305.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13020305</ArticleId><ArticleId IdType="pmc">PMC7919488</ArticleId><ArticleId IdType="pubmed">33672054</ArticleId></ArticleIdList></Reference><Reference><Citation>Melchart D., Linde K., Fischer P., Kaesmayr J. Echinacea for preventing and treating the common cold. Cochrane Database Syst. Rev. 2000;2:CD000530. doi: 10.1002/14651858.CD000530.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD000530</ArticleId><ArticleId IdType="pubmed">10796553</ArticleId></ArticleIdList></Reference><Reference><Citation>Giles J.T., Palat C.T., 3rd, Chien S.H., Chang Z.G., Kennedy D.T. Evaluation of echinacea for treatment of the common cold. Pharmacotherapy. 2000;20:690&#x2013;697. doi: 10.1592/phco.20.7.690.35173.</Citation><ArticleIdList><ArticleId IdType="doi">10.1592/phco.20.7.690.35173</ArticleId><ArticleId IdType="pmc">PMC7167769</ArticleId><ArticleId IdType="pubmed">10853625</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor J.A., Weber W., Standish L., Quinn H., Goesling J., McGann M., Calabrese C. Efficacy and safety of echinacea in treating upper respiratory tract infections in children: A randomized controlled trial. JAMA. 2003;290:2824&#x2013;2830. doi: 10.1001/jama.290.21.2824.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.290.21.2824</ArticleId><ArticleId IdType="pubmed">14657066</ArticleId></ArticleIdList></Reference><Reference><Citation>Riemma G., Schettino M.T., Munno G.M., Fasulo D.D., Sandullo L., Amabile E., La Verde M., Torella M. Echinacea angustifolia and Echinacea purpurea Supplementation Combined with Vaginal Hyaluronic Acid to Boost the Remission of Cervical Low-Grade Squamous Intraepithelial Lesions (L-SILs): A Randomized Controlled Trial. Medicina. 2022;58:646. doi: 10.3390/medicina58050646.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina58050646</ArticleId><ArticleId IdType="pmc">PMC9145219</ArticleId><ArticleId IdType="pubmed">35630063</ArticleId></ArticleIdList></Reference><Reference><Citation>De Rosa N., Giampaolino P., Lavitola G., Morra I., Formisano C., Nappi C., Bifulco G. Effect of Immunomodulatory Supplements Based on Echinacea Angustifolia and Echinacea Purpurea on the Posttreatment Relapse Incidence of Genital Condylomatosis: A Prospective Randomized Study. Biomed. Res. Int. 2019;2019:3548396. doi: 10.1155/2019/3548396.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/3548396</ArticleId><ArticleId IdType="pmc">PMC6487159</ArticleId><ArticleId IdType="pubmed">31111049</ArticleId></ArticleIdList></Reference><Reference><Citation>Roman I., Stanila A., Stanila S. Bioactive compounds and antioxidant activity of Rosa canina L. biotypes from spontaneous flora of Transylvania. Chem. Cent. J. 2013;7:73. doi: 10.1186/1752-153X-7-73.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1752-153X-7-73</ArticleId><ArticleId IdType="pmc">PMC3668991</ArticleId><ArticleId IdType="pubmed">23618509</ArticleId></ArticleIdList></Reference><Reference><Citation>Deliorman Orhan D., Hartevioglu A., Kupeli E., Yesilada E. In vivo anti-inflammatory and antinociceptive activity of the crude extract and fractions from Rosa canina L. fruits. J. Ethnopharmacol. 2007;112:394&#x2013;400. doi: 10.1016/j.jep.2007.03.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jep.2007.03.029</ArticleId><ArticleId IdType="pubmed">17482395</ArticleId></ArticleIdList></Reference><Reference><Citation>Jager A.K., Eldeen I.M., van Staden J. COX-1 and -2 activity of rose hip. Phytother. Res. 2007;21:1251&#x2013;1252. doi: 10.1002/ptr.2236.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ptr.2236</ArticleId><ArticleId IdType="pubmed">17639563</ArticleId></ArticleIdList></Reference><Reference><Citation>Winther K., Apel K., Thamsborg G. A powder made from seeds and shells of a rose-hip subspecies (Rosa canina) reduces symptoms of knee and hip osteoarthritis: A randomized, double-blind, placebo-controlled clinical trial. Scand. J. Rheumatol. 2005;34:302&#x2013;308. doi: 10.1080/03009740510018624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/03009740510018624</ArticleId><ArticleId IdType="pubmed">16195164</ArticleId></ArticleIdList></Reference><Reference><Citation>Winther K., Rein E., Kharazmi A. The anti-inflammatory properties of rose-hip. Inflammopharmacology. 1999;7:63&#x2013;68. doi: 10.1007/s10787-999-0026-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10787-999-0026-8</ArticleId><ArticleId IdType="pubmed">17657447</ArticleId></ArticleIdList></Reference><Reference><Citation>Kharazmi A., Winther K. Rose hip inhibits chemotaxis and chemiluminescence of human peripheral blood neutrophils in vitro and reduces certain inflammatory parameters in vivo. Inflammopharmacology. 1999;7:377&#x2013;386. doi: 10.1007/s10787-999-0031-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10787-999-0031-y</ArticleId><ArticleId IdType="pubmed">17657440</ArticleId></ArticleIdList></Reference><Reference><Citation>Cornara L., Biagi M., Xiao J., Burlando B. Therapeutic Properties of Bioactive Compounds from Different Honeybee Products. Front. Pharmacol. 2017;8:412. doi: 10.3389/fphar.2017.00412.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2017.00412</ArticleId><ArticleId IdType="pmc">PMC5487425</ArticleId><ArticleId IdType="pubmed">28701955</ArticleId></ArticleIdList></Reference><Reference><Citation>Bueno-Silva B., Kawamoto D., Ando-Suguimoto E.S., Casarin R.C.V., Alencar S.M., Rosalen P.L., Mayer M.P.A. Brazilian red propolis effects on peritoneal macrophage activity: Nitric oxide, cell viability, pro-inflammatory cytokines and gene expression. J. Ethnopharmacol. 2017;207:100&#x2013;107. doi: 10.1016/j.jep.2017.06.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jep.2017.06.015</ArticleId><ArticleId IdType="pubmed">28624363</ArticleId></ArticleIdList></Reference><Reference><Citation>Botezan S., Baci G.M., Bagameri L., Pasca C., Dezmirean D.S. Current Status of the Bioactive Properties of Royal Jelly: A Comprehensive Review with a Focus on Its Anticancer, Anti-Inflammatory, and Antioxidant Effects. Molecules. 2023;28:1510. doi: 10.3390/molecules28031510.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules28031510</ArticleId><ArticleId IdType="pmc">PMC9921556</ArticleId><ArticleId IdType="pubmed">36771175</ArticleId></ArticleIdList></Reference><Reference><Citation>Honda Y., Araki Y., Hata T., Ichihara K., Ito M., Tanaka M., Honda S. 10-Hydroxy-2-decenoic Acid, the Major Lipid Component of Royal Jelly, Extends the Lifespan of Caenorhabditis elegans through Dietary Restriction and Target of Rapamycin Signaling. J. Aging Res. 2015;2015:425261. doi: 10.1155/2015/425261.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/425261</ArticleId><ArticleId IdType="pmc">PMC4350847</ArticleId><ArticleId IdType="pubmed">25789174</ArticleId></ArticleIdList></Reference><Reference><Citation>Terada Y., Narukawa M., Watanabe T. Specific hydroxy fatty acids in royal jelly activate TRPA1. J. Agric. Food Chem. 2011;59:2627&#x2013;2635. doi: 10.1021/jf1041646.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jf1041646</ArticleId><ArticleId IdType="pubmed">21348496</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshida M., Hayashi K., Watadani R., Okano Y., Tanimura K., Kotoh J., Sasaki D., Matsumoto K., Maeda A. Royal jelly improves hyperglycemia in obese/diabetic KK-Ay mice. J. Vet. Med. Sci. 2017;79:299&#x2013;307. doi: 10.1292/jvms.16-0458.</Citation><ArticleIdList><ArticleId IdType="doi">10.1292/jvms.16-0458</ArticleId><ArticleId IdType="pmc">PMC5326934</ArticleId><ArticleId IdType="pubmed">27890887</ArticleId></ArticleIdList></Reference><Reference><Citation>Vajdi M., Musazadeh V., Khajeh M., Safaei E., Darzi M., Noshadi N., Bazyar H., Askari G. The effects of royal jelly supplementation on anthropometric indices: A GRADE-assessed systematic review and dose-response meta-analysis of randomized controlled trials. Front. Nutr. 2023;10:1196258. doi: 10.3389/fnut.2023.1196258.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2023.1196258</ArticleId><ArticleId IdType="pmc">PMC10438987</ArticleId><ArticleId IdType="pubmed">37599677</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariani E., Cattini L., Neri S., Malavolta M., Mocchegiani E., Ravaglia G., Facchini A. Simultaneous evaluation of circulating chemokine and cytokine profiles in elderly subjects by multiplex technology: Relationship with zinc status. Biogerontology. 2006;7:449&#x2013;459. doi: 10.1007/s10522-006-9060-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10522-006-9060-8</ArticleId><ArticleId IdType="pubmed">16967203</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad A.S. Zinc in human health: Effect of zinc on immune cells. Mol. Med. 2008;14:353&#x2013;357. doi: 10.2119/2008-00033.Prasad.</Citation><ArticleIdList><ArticleId IdType="doi">10.2119/2008-00033.Prasad</ArticleId><ArticleId IdType="pmc">PMC2277319</ArticleId><ArticleId IdType="pubmed">18385818</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon S.Y., Park H.W., Kim H.J., Kronbichler A., Koyanagi A., Smith L., Shin J.I., Rhee S.Y., Lee S.W., Kim J.S., et al. National trends in the prevalence of chronic kidney disease among Korean adults, 2007&#x2013;2020. Sci. Rep. 2023;13:5831. doi: 10.1038/s41598-023-33122-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-33122-1</ArticleId><ArticleId IdType="pmc">PMC10086041</ArticleId><ArticleId IdType="pubmed">37037823</ArticleId></ArticleIdList></Reference><Reference><Citation>Cobo G., Lindholm B., Stenvinkel P. Chronic inflammation in end-stage renal disease and dialysis. Nephrol. Dial. Transpl. 2018;33:iii35&#x2013;iii40. doi: 10.1093/ndt/gfy175.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfy175</ArticleId><ArticleId IdType="pmc">PMC6168801</ArticleId><ArticleId IdType="pubmed">30281126</ArticleId></ArticleIdList></Reference><Reference><Citation>Younis H.A., Nafady M.A., Mahmoud M. Value of carotid intimal&#x2013;medial thickness as independent predictor of endothelial dysfunction in uremic patients. Egypt. Heart J. 2011;63:73&#x2013;78. doi: 10.1016/j.ehj.2011.09.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ehj.2011.09.008</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs J.J.L. Persistent SARS-2 infections contribute to long COVID-19. Med. Hypotheses. 2021;149:110538. doi: 10.1016/j.mehy.2021.110538.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2021.110538</ArticleId><ArticleId IdType="pmc">PMC7884250</ArticleId><ArticleId IdType="pubmed">33621843</ArticleId></ArticleIdList></Reference><Reference><Citation>Ninfali P., Mea G., Giorgini S., Rocchi M., Bacchiocca M. Antioxidant capacity of vegetables, spices and dressings relevant to nutrition. Br. J. Nutr. 2005;93:257&#x2013;266. doi: 10.1079/BJN20041327.</Citation><ArticleIdList><ArticleId IdType="doi">10.1079/BJN20041327</ArticleId><ArticleId IdType="pubmed">15788119</ArticleId></ArticleIdList></Reference><Reference><Citation>Societ&#xe0; Italiana di Nutrizione Umana (SINU). MINERALI&#x2014;Livello Massimo Tollerabile di Assunzione (UL) e Obiettivo Nutrizionale per la Popolazione (SDT)  [(accessed on 8 March 2024)].  Available online:  https://sinu.it/2019/07/09/minerali-livello-massimo-tollerabile-di-assunzione-ul-e-obiettivo-nutrizionale-per-la-popolazione-sdt/</Citation></Reference><Reference><Citation>Bonaventura P., Benedetti G., Albarede F., Miossec P. Zinc and its role in immunity and inflammation. Autoimmun. Rev. 2015;14:277&#x2013;285. doi: 10.1016/j.autrev.2014.11.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2014.11.008</ArticleId><ArticleId IdType="pubmed">25462582</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarosz M., Olbert M., Wyszogrodzka G., Mlyniec K., Librowski T. Antioxidant and anti-inflammatory effects of zinc. Zinc-dependent NF-kappaB signaling. Inflammopharmacology. 2017;25:11&#x2013;24. doi: 10.1007/s10787-017-0309-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10787-017-0309-4</ArticleId><ArticleId IdType="pmc">PMC5306179</ArticleId><ArticleId IdType="pubmed">28083748</ArticleId></ArticleIdList></Reference><Reference><Citation>Noce A., Bocedi A., Campo M., Marrone G., Di Lauro M., Cattani G., Di Daniele N., Romani A. A Pilot Study of a Natural Food Supplement as New Possible Therapeutic Approach in Chronic Kidney Disease Patients. Pharmaceuticals. 2020;13:148. doi: 10.3390/ph13070148.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph13070148</ArticleId><ArticleId IdType="pmc">PMC7408446</ArticleId><ArticleId IdType="pubmed">32664308</ArticleId></ArticleIdList></Reference><Reference><Citation>Cannell J.J., Grant W.B., Holick M.F. Vitamin D and inflammation. Dermatoendocrinol. 2014;6:e983401. doi: 10.4161/19381980.2014.983401.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/19381980.2014.983401</ArticleId><ArticleId IdType="pmc">PMC4580066</ArticleId><ArticleId IdType="pubmed">26413186</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin K., Agrawal D.K. Vitamin D and inflammatory diseases. J. Inflamm. Res. 2014;7:69&#x2013;87. doi: 10.2147/JIR.S63898.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JIR.S63898</ArticleId><ArticleId IdType="pmc">PMC4070857</ArticleId><ArticleId IdType="pubmed">24971027</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy S., Sherman A., Monari-Sparks M.J., Schweiker O., Hunter K. Correction of Low Vitamin D Improves Fatigue: Effect of Correction of Low Vitamin D in Fatigue Study (EViDiF Study) N. Am. J. Med. Sci. 2014;6:396&#x2013;402. doi: 10.4103/1947-2714.139291.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1947-2714.139291</ArticleId><ArticleId IdType="pmc">PMC4158648</ArticleId><ArticleId IdType="pubmed">25210673</ArticleId></ArticleIdList></Reference><Reference><Citation>Nowak A., Boesch L., Andres E., Battegay E., Hornemann T., Schmid C., Bischoff-Ferrari H.A., Suter P.M., Krayenbuehl P.A. Effect of vitamin D3 on self-perceived fatigue: A double-blind randomized placebo-controlled trial. Medicine. 2016;95:e5353. doi: 10.1097/MD.0000000000005353.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000005353</ArticleId><ArticleId IdType="pmc">PMC5207540</ArticleId><ArticleId IdType="pubmed">28033244</ArticleId></ArticleIdList></Reference><Reference><Citation>Singleton V.L., Orthofer R., Lamuela-Ravent&#xf3;s R.M. Methods in Enzymology. Volume 299. Academic Press; London, UK: 1999. Analysis of total phenols and other oxidation substrates and antioxidants by means of folin-ciocalteu reagent; pp. 152&#x2013;178.</Citation></Reference><Reference><Citation>Gulcin &#x130;., Alwasel S.H. DPPH Radical Scavenging Assay. Processes. 2023;11:2248. doi: 10.3390/pr11082248.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pr11082248</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams B., Mancia G., Spiering W., Agabiti Rosei E., Azizi M., Burnier M., Clement D.L., Coca A., de Simone G., Dominiczak A., et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J. Hypertens. 2018;36:1953&#x2013;2041. doi: 10.1097/HJH.0000000000001940.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/HJH.0000000000001940</ArticleId><ArticleId IdType="pubmed">30234752</ArticleId></ArticleIdList></Reference><Reference><Citation>Lohman T.G., Roche F.A., Martorell R. Anthropometric Standardization Reference Manual. Human Kinetics; Champaign, IL, USA: 1998.</Citation></Reference><Reference><Citation>Bellizzi V., Scalfi L., Terracciano V., De Nicola L., Minutolo R., Marra M., Guida B., Cianciaruso B., Conte G., Di Iorio B.R. Early changes in bioelectrical estimates of body composition in chronic kidney disease. J. Am. Soc. Nephrol. 2006;17:1481&#x2013;1487. doi: 10.1681/ASN.2005070756.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2005070756</ArticleId><ArticleId IdType="pubmed">16611719</ArticleId></ArticleIdList></Reference><Reference><Citation>Burholt V., Nash P. Short Form 36 (SF-36) Health Survey Questionnaire: Normative data for Wales. J. Public. Health. 2011;33:587&#x2013;603. doi: 10.1093/pubmed/fdr006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/pubmed/fdr006</ArticleId><ArticleId IdType="pubmed">21307049</ArticleId></ArticleIdList></Reference><Reference><Citation>Naik H., Shao S., Tran K.C., Wong A.W., Russell J.A., Khor E., Nacul L., McKay R.J., Carlsten C., Ryerson C.J., et al. Evaluating fatigue in patients recovering from COVID-19: Validation of the fatigue severity scale and single item screening questions. Health Qual. Life Outcomes. 2022;20:170. doi: 10.1186/s12955-022-02082-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12955-022-02082-x</ArticleId><ArticleId IdType="pmc">PMC9792925</ArticleId><ArticleId IdType="pubmed">36575437</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker N.A., Sunderram J., Zhang P., Lu S.E., Scharf M.T. Clinical utility of the Epworth sleepiness scale. Sleep. Breath. 2020;24:1759&#x2013;1765. doi: 10.1007/s11325-020-02015-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11325-020-02015-2</ArticleId><ArticleId IdType="pubmed">31938991</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez-Gonzalez M.A., Garcia-Arellano A., Toledo E., Salas-Salvado J., Buil-Cosiales P., Corella D., Covas M.I., Schroder H., Aros F., Gomez-Gracia E., et al. A 14-item Mediterranean diet assessment tool and obesity indexes among high-risk subjects: The PREDIMED trial. PLoS ONE. 2012;7:e43134. doi: 10.1371/journal.pone.0043134.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0043134</ArticleId><ArticleId IdType="pmc">PMC3419206</ArticleId><ArticleId IdType="pubmed">22905215</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>